Health · 5 views
Trump inks deal with 9 pharmaceutical companies to lower drug costs
The White House said the agreements will reduce costs to treat Parkinson's disease, macular degeneration, glaucoma, liver disease and other illnesses.
Story Brief
President Trump said Monday that his administration has signed agreements with nine additional pharmaceutical firms to offer discounted drugs to state Medicaid programs. "In total, these agreements are projected to save Americans more than $600 billion over a very short period of time," Mr. Trump said during an announcement at the Oval Office.
Read full article on CBS NewsAI summaries can be wrong sometimes—always verify important details using the source article.
How AI & Automation are usedMore from Health
Continue reading recent Health coverage
- Digital strategy helps patients with heart failure to receive proven medicationContinue reading
- After TAVI, anticoagulants outperform antiplatelet agents at preventing clotsContinue reading
- Public confidence in one's own health care provider remains highContinue reading
- High fertility costs push Americans abroad for IVF treatmentContinue reading
Support HappeningNow
Independent AI-powered news analysis is reader-supported. Your contribution helps cover infrastructure, summaries, and continued platform development.
Support HappeningNow